
Loading, please wait...

Loading, please wait...

The research revealed an overall complication rate of 11.92% across ten different departments. Specifically, the most frequent issue was the worsening of anterior pituitary function. This affected 4.80% of the surgical cases. Meanwhile, permanent diabetes insipidus occurred in 2.32% of patients. Furthermore, 1.49% of individuals developed postoperative cerebrospinal fluid (CSF) leaks. Because other risks like carotid artery injury or visual worsening were rare, surgeons consider the procedure safe. However, clinicians must remain vigilant since these outcomes impact recovery and long-term health.
Another important finding relates to the learning curve of the surgical team. Surprisingly, the complication rate followed a U-shaped progression during the study period. This means that surgeons in the middle experience group, with 50 to 200 cases, had higher rates than novices or experts. Perhaps this happens because intermediate surgeons attempt more complex cases while novices stick to simpler ones. Additionally, nonfunctioning adenomas and recurrent tumors increased the risk profile significantly. Therefore, tailored management strategies are crucial for patient safety and better clinical results.
The study identifies the worsening of anterior pituitary function as the most frequent complication, occurring in 4.80% of patients. Permanent diabetes insipidus follows at a rate of 2.32%.
There is a U-shaped trend where surgeons with intermediate experience (50 to 200 cases) show higher rates. This highlights the need for continued mentorship during the middle stages of a neurosurgeon's career.
Research suggests that nonfunctioning adenomas and recurrent tumors are more frequently associated with complications. Surgeons should adjust their operative plans when treating these specific tumor types.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
d'Avella E et al. Complications in endoscopic endonasal surgery for pituitary neuroendocrine tumors: an Italian multicenter study. J Neurosurg. 2026 Mar 13. doi: 10.3171/2025.10.JNS251394. PMID: 41825079.
Ghorbani M et al. Complications in Endoscopic Endonasal Pituitary Adenoma Surgery: An Institution Experience in 310 Patients. J Neurol Surg B Skull Base. 2022 Jul 5;84(3):255-265. doi: 10.1055/a-1838-5897.
Agam MS et al. Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases. J Neurosurg. 2018 Jun 1;130(5):1610-1617. doi: 10.3171/2018.1.JNS172343.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Italian multicenter study of 3,356 endoscopic PitNET removals finds an 11.92% complication rate, with endocrine worsening and DI being the most frequent....
7 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday